Danaher reported third-quarter 2026 sales of $6.6 billion, up 8.5% year over year, and net earnings of $1.2 billion, or $1.71 per diluted share, up 34.5%. Adjusted diluted EPS rose 11.5% to $2.11, and the company raised its full-year 2026 adjusted EPS guidance to $8.57-$8.62 from $8.45-$8.60. For shareholders, the results and higher guidance point to stronger profit, though core revenue growth excluding respiratory testing was 5.5%, and the company expects respiratory testing to be a headwind in the fourth quarter.
Third-quarter net earnings were $1.2 billion, or $1.71 per diluted share, up 34.5% year over year.
Adjusted diluted EPS was $2.11, up 11.5% from $1.89 a year earlier.
Full-year 2026 adjusted diluted EPS guidance was raised to $8.57-$8.62 from $8.45-$8.60.
Core revenue excluding respiratory testing rose 5.5%; total core revenue rose 3.0%.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Danaher Corporation's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$24.57B
+2.9%
$5.05
-4.5%
14.7%
FY2024
$23.88B
-0.1%
$5.29
-17.1%
16.3%
FY2023
$23.89B
-10.3%
$6.38
-34.0%
19.9%
FY2022
$26.64B
+7.4%
$9.66
+12.2%
27.1%
FY2021
$24.80B
+11.3%
$8.61
+76.1%
25.9%
Frequently asked questions
When is Danaher's next earnings date?
Danaher has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Danaher earn last quarter?
For the quarter ended Sep 2026, Danaher reported diluted EPS of $1.75 (+37.8% year over year) on revenue of $6.55B (+8.3%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.